| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $33.0M | +33.1% | +107.5% |
| SG&A Expense | $7.7M | +6.7% | +61.6% |
| Operating Income | -$40.7M | -27.0% | -97.2% |
| Pre-tax Income | -$36.3M | -32.8% | -107.6% |
| Income Tax | $40K | -23.1% | — |
| Net Income | -$36.3M | -32.6% | -107.8% |
| EPS (Basic) | -$0.67 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $171.7M | -60.7% | -67.0% |
| Short-term Investments | $118.5M | — | — |
| Current Assets | $297.4M | -33.1% | -43.0% |
| Total Assets | $424.7M | -6.4% | -19.0% |
| Current Liabilities | $21.0M | +22.1% | +45.2% |
| Total Liabilities | $21.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$82.9M | — | — |
| Capital Expenditures | $42K | — | — |
| Investing Cash Flow | -$236.1M | — | — |
| Financing Cash Flow | $1.0M | — | — |
| Free Cash Flow | -$83.0M | — | — |
| -34.0% |
| +58.1% |
| EPS (Diluted) | -$0.67 | -34.0% | +58.1% |
| +19.1% |
| +49.9% |
| Stockholders' Equity | $402.8M | -7.4% | -21.0% |